Jon Faiz Kayyem - 06 Dec 2021 Form 4 Insider Report for BIODESIX INC (BDSX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BDSX	Restricted Stock Units	Award	$0	+31,619	$0.000000	31,619	06 Dec 2021	Common Stock	31,619		Direct	F1, F2
transaction	BDSX	Stock Options (Right to Buy)	Award	$0	+50,368	$0.000000	50,368	06 Dec 2021	Common Stock	50,368	$5.93	Direct	F3
transaction	BDSX	Stock Options (Right to Buy)	Award	$0	+27,038	$0.000000	27,038	07 Dec 2021	Common Stock	27,038	$5.67	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2	These restricted stock units will vest in full on December 6, 2022, generally subject to the reporting person's continued service on the Issuer's board of directors (the "Board") through the applicable vesting date, and have no expiration date.
F3	This option vests 40% on December 6, 2023, and the remaining 60% in 36 successive, equal monthly installments measured from December 6, 2023, generally subject to the reporting person's continued service on the Board through the applicable vesting date.
F4	This option will vest in full on March 31, 2022, subject to the reporting person's continued service on the Board through the applicable vesting date. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period.